Capsulized Fecal Microbiota Transplantation Induces Remission in Patients with Ulcerative Colitis by Gut Microbial Colonization and Metabolite Regulation

被引:17
|
作者
Chen, Qiongyun [1 ,2 ]
Fan, Yanyun [1 ]
Zhang, Bangzhou [1 ,2 ]
Yan, Changsheng [1 ,2 ]
Zhang, Qiang [1 ]
Ke, Yuhao [1 ]
Chen, Zhangran [1 ,2 ]
Wang, Lin [1 ]
Shi, Huaxiu [1 ]
Hu, Yiqun [1 ]
Huang, Qingwen [1 ]
Su, Jingling [1 ]
Xie, Chenxi [1 ]
Zhang, Xu [1 ]
Zhou, Lixiang [1 ]
Ren, Jianlin [1 ,2 ,3 ,4 ]
Xu, Hongzhi [1 ,2 ,3 ,4 ]
机构
[1] Xiamen Univ, Sch Med, Zhongshan Hosp, Dept Gastroenterol, Xiamen, Peoples R China
[2] Xiamen Univ, Sch Med, Inst Microbial Ecol, Xiamen, Peoples R China
[3] Xiamen Univ, Xiamen Key Lab Intestinal Microbiome & Human Hlth, Zhongshan Hosp, Xiamen, Peoples R China
[4] Xiamen Univ, Sch Med, Dept Digest Dis, Xiamen, Peoples R China
来源
MICROBIOLOGY SPECTRUM | 2023年 / 11卷 / 03期
关键词
fecal microbiota transplantation; ulcerative colitis; capsules; microbiome; gut microbiome; metabolism; INFLAMMATORY-BOWEL-DISEASE; ESCHERICHIA-COLI; LIPOPOLYSACCHARIDE; PREVALENCE; SEQUENCES; THERAPY; IBD;
D O I
10.1128/spectrum.04152-22
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Fecal microbiota transplantation (FMT) can induce clinical remission in ulcerative colitis (UC) patients. Enemas, nasoduodenal tubes, and colonoscopies are the most common routes for FMT administration. However, there is a lack of definitive evidence regarding the effectiveness of capsulized FMT treatment in UC patients. In this study, we administered capsulized FMT to 22 patients with active UC to assess the efficiency of capsulized FMT and determine the specific bacteria and metabolite factors associated with the response to clinical remission. Our results showed that the use of capsulized FMT was successful in the treatment of UC patients. Capsulized FMT induced clinical remission and clinical response in 57.1% (12 of 21) and 76.2% (16 of 21) of UC patients, respectively. Gut bacterial richness was increased after FMT in patients who achieved remission. Patients in remission after FMT exhibited enrichment of Alistipes sp. and Odoribacter splanchnicus, along with increased levels of indolelactic acid. Patients who did not achieve remission exhibited enrichment of Escherichia coli and Klebsiella and increased levels of biosynthesis of 12,13-DiHOME (12,13-dihydroxy-9Z-octadecenoic acid) and lipopolysaccharides. Furthermore, we identified a relationship between specific bacteria and metabolites and the induction of remission in patients. These findings may provide new insights into FMT in UC treatment and provide reference information about therapeutic microbial manipulation of FMT to enhance its effects. (This study has been registered at ClinicalTrails.gov under registration no. NCT03426683). IMPORTANCE Fecal microbiota transplantation has been successfully used in patients. Recently, capsulized FMT was reported to induce a response in patients with UC. However, limited patients were enrolled in such studies, and the functional factors of capsulized FMT have not been reported in the remission of patients with UC. In this study, we prospectively recruited patients with UC to receive capsulized FMT. First, we found that capsulized FMT could induce clinical remission in 57.1% of patients and clinical response in 76.2% after 12weeks, which was more acceptable. Second, we found a relationship between the decrease of opportunistic pathogen and lipopolysaccharide synthesis in patients in remission after capsulized FMT. We also identified an association between specific bacteria and metabolites and remission induction in patients after capsulized FMT. These findings put forward a possibility for patients to receive FMT at home and provide reference information about therapeutic microbial manipulation of FMT to enhance its effects.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] Role of Fecal Microbiota Transplantation in Patients with Steroid Dependant Ulcerative Colitis
    Grewal, Charanpreet S.
    Sood, Ajit
    Mehta, Varun
    Sood, Neena
    Midha, Vandana
    Mahajan, Ramit
    Kaur, Dilpreet
    Singh, Dharmatma
    Bhardwaj, Payal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S1252 - S1253
  • [22] Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis A Randomized Clinical Trial
    Costello, Samuel P.
    Hughes, Patrick A.
    Waters, Oliver
    Bryant, Robert, V
    Vincent, Andrew D.
    Blatchford, Paul
    Katsikeros, Rosa
    Makanyanga, Jesica
    Campaniello, Melissa A.
    Mavrangelos, Chris
    Rosewarne, Carly P.
    Bickley, Chelsea
    Peters, Cian
    Schoeman, Mark N.
    Conlon, Michael A.
    Roberts-Thomson, Ian C.
    Andrews, Jane M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (02): : 156 - 164
  • [23] The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis
    Lam, Wai Ching
    Zhao, Chen
    Ma, Wen Juan
    Yao, Liang
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2019, 2019
  • [24] Alteration of Intestinal Dysbiosis by Fecal Microbiota Transplantation Does not Induce Remission in Patients with Chronic Active Ulcerative Colitis
    Kump, Patrizia K.
    Groechenig, Hans-Peter
    Lackner, Stefan
    Trajanoski, Slave
    Reicht, Gerhard
    Hoffmann, K. Martin
    Deutschmann, Andrea
    Wenzl, Heimo H.
    Petritsch, Wolfgang
    Krejs, Guenter J.
    Gorkiewicz, Gregor
    Hoegenauer, Christoph
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (10) : 2155 - 2165
  • [25] Fecal Microbiota Transplantation Inducing Remission in Crohn's Colitis and the Associated Changes in Fecal Microbial Profile
    Kao, Dina
    Hotte, Naomi
    Gillevet, Patrick
    Madsen, Karen
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2014, 48 (07) : 625 - 628
  • [26] Dynamics of Gut Microbiota After Fecal Microbiota Transplantation in Ulcerative Colitis: Success Linked to Control of Prevotellaceae
    Pinto, Susanne
    Sajbenova, Dominika
    Beninca, Elisa
    Nooij, Sam
    Terveer, Elisabeth M.
    Keller, Josbert J.
    van der Meulen-de Jong, Andrea E.
    Bogaards, Johannes A.
    Steyerberg, Ewout W.
    JOURNAL OF CROHNS & COLITIS, 2024, 19 (02):
  • [27] Gut microbiota profiling and disease course in patients with ulcerative colitis in clinical remission
    Singh, A. D. M.
    Sundharam, S. S.
    Midha, V.
    Singh, D.
    Mahajan, R.
    Krishnamurthi, S.
    Sood, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2139 - I2141
  • [28] Patient Perceptions of Fecal Microbiota Transplantation for Ulcerative Colitis
    Kahn, Stacy A.
    Vachon, Ashley I.
    Marks, Julia A.
    Surma, Bonnie L.
    Rodriquez, Dylan M.
    Goeppinger, Sarah R.
    Rubin, David T.
    GASTROENTEROLOGY, 2012, 142 (05) : S357 - S357
  • [29] Repeated fecal microbiota transplantation in a child with ulcerative colitis
    Shimizu, Hirotaka
    Arai, Katsuhiro
    Abe, Jun
    Nakabayashi, Kazuhiko
    Yoshioka, Takako
    Hosoi, Kenji
    Kuroda, Makoto
    PEDIATRICS INTERNATIONAL, 2016, 58 (08) : 781 - 785
  • [30] Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy
    Sood, Ajit
    Singh, Arshdeep
    Midha, Vandana
    Mahajan, Ramit
    Kao, Dina
    Rubin, David T.
    Bernstein, Charles N.
    CROHNS & COLITIS 360, 2020, 2 (04) : 1 - 7